|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-10-23
|
|
pubmed:abstractText |
Large-scale studies have indicated that treatment with angiotensin converting enzyme (ACE) inhibitors reduces the incidence of myocardial infarction and unstable angina pectoris among patients with recent myocardial infarction and moderate left ventricular dysfunction. An improved endogenous fibrinolysis might be responsible for this effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0954-6928
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
283-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9285181-Aged,
pubmed-meshheading:9285181-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9285181-Double-Blind Method,
pubmed-meshheading:9285181-Fibrinolysis,
pubmed-meshheading:9285181-Genotype,
pubmed-meshheading:9285181-Humans,
pubmed-meshheading:9285181-Indoles,
pubmed-meshheading:9285181-Male,
pubmed-meshheading:9285181-Middle Aged,
pubmed-meshheading:9285181-Myocardial Infarction,
pubmed-meshheading:9285181-Peptidyl-Dipeptidase A,
pubmed-meshheading:9285181-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:9285181-Tissue Plasminogen Activator,
pubmed-meshheading:9285181-Ventricular Dysfunction, Left
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
|
|
pubmed:affiliation |
Department of Internal Medicine, Ribe County Hospital in Esbjerg, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
